Oral vs Injectable Semaglutide: A Prescription Decision Guide

With oral Wegovy now available at $149/month, the pill-vs-injection question is one every GLP-1 patient faces. Here's a clinical comparison to help you decide.

Clinical Comparison

Factor	Oral (25mg daily)	Injectable (2.4mg weekly)	HD Injectable (7.2mg)
Weight loss (adherent)	16.6%	~15%	20.7%
Dosing frequency	Daily	Weekly	Weekly
Self-pay cost	$149/mo	$349+/mo	TBD
Needles	None	Auto-injector	Auto-injector
Food restrictions	30-min fast required	None	None
Refrigeration	Not needed	Required	Required

Best Candidates for the Pill

• Needle-averse patients
• Frequent travelers (no cold chain)
• Cost-conscious patients without insurance coverage
• Patients who can maintain a consistent morning routine with 30-min fasting

Best Candidates for Injections

• Patients who prefer once-weekly dosing over daily compliance
• Those needing maximum potency (Wegovy HD at 7.2mg)
• Patients taking multiple morning medications (oral Wegovy has interaction timing concerns)
• Those with GI conditions that might affect oral absorption

Provider Options

The Bottom Line

Both deliver clinically meaningful weight loss. The pill wins on cost and convenience for needle-averse patients. Injections win on dosing simplicity and maximum potency (especially with Wegovy HD). There's no wrong choice — it's about matching the formulation to your lifestyle and preferences.